Klara Komici1,2, Antonio Bianco1,2, Fabio Perrotta3, Antonio Dello Iacono4, Leonardo Bencivenga5,6, Vito D'Agnano1, Aldo Rocca1, Andrea Bianco7, Giuseppe Rengo5,8, Germano Guerra1,2. 1. Department of Medicine and Health Sciences, University of Molise, 86100 Campobasso, Italy. 2. Exercise and Sports Medicine Unit, "Antonio Cardarelli Hospital", 86100 Campobasso, Italy. 3. UOC Pneumologia AORN Sant'Anna e San Sebastiano, 81100 Caserta, Italy. 4. School of Health and Life Sciences, University of the West of Scotland, Hamilton G72 0LH, UK. 5. Department of Translational Medical Sciences, University of Naples "Federico II", 80131 Naples, Italy. 6. Department of Advanced Biomedical Sciences, University of Naples "Federico II", 80131 Naples, Italy. 7. Department of Translational Medical Sciences, University of Campania "L. Vanvitelli", 80138 Naples, Italy. 8. Istituti Clinici Scientifici Maugeri SpA Società Benefit (ICS Maugeri SpA SB), 82037 Telese Terme, Italy.
Abstract
BACKGROUND: Limited evidence exists regarding adverse modifications affecting cardiovascular and pulmonary function in physical active adults affected by COVID-19, especially in athletic populations. We aimed to describe the clinical presentation of COVID-19 in a cohort of competitive athletes, as well as spirometry and echocardiography findings and cardio-respiratory performance during exercise. METHODS: Twenty-four competitive athletes with COVID-19 were recruited for this study after ending self-isolation and confirmation of negative laboratory results. All athletes underwent clinical evaluation, spirometry, echocardiography and cardiopulmonary exercise testing (CPET). These data were compared to a group of healthy control athletes. RESULTS: Anosmia was the most frequent symptom present in 70.83% patients, followed by myalgia, fatigue and ageusia. The most frequent persisting symptoms were anosmia 11 (45.83%) and ageusia 8 (33.33%). Compared to controls, COVID-19 patients presented lower FEV1%: 97.5 (91.5-108) vs. 109 (106-116) p = 0.007. Peak Oxygen Uptake (VO2) in COVID-19 patients was 50.1 (47.7-51.65) vs. 49 (44.2-52.6) in controls (p = 0.618). CONCLUSIONS: Reduced exercise capacity was not identified and pulmonary and cardiovascular function are not impaired during early recovery phase in a population of physical active adults except FEV1 reduction.
BACKGROUND: Limited evidence exists regarding adverse modifications affecting cardiovascular and pulmonary function in physical active adults affected by COVID-19, especially in athletic populations. We aimed to describe the clinical presentation of COVID-19 in a cohort of competitive athletes, as well as spirometry and echocardiography findings and cardio-respiratory performance during exercise. METHODS: Twenty-four competitive athletes with COVID-19 were recruited for this study after ending self-isolation and confirmation of negative laboratory results. All athletes underwent clinical evaluation, spirometry, echocardiography and cardiopulmonary exercise testing (CPET). These data were compared to a group of healthy control athletes. RESULTS:Anosmia was the most frequent symptom present in 70.83% patients, followed by myalgia, fatigue and ageusia. The most frequent persisting symptoms were anosmia 11 (45.83%) and ageusia 8 (33.33%). Compared to controls, COVID-19patients presented lower FEV1%: 97.5 (91.5-108) vs. 109 (106-116) p = 0.007. Peak Oxygen Uptake (VO2) in COVID-19patients was 50.1 (47.7-51.65) vs. 49 (44.2-52.6) in controls (p = 0.618). CONCLUSIONS: Reduced exercise capacity was not identified and pulmonary and cardiovascular function are not impaired during early recovery phase in a population of physical active adults except FEV1 reduction.
Authors: Nathaniel Moulson; Sarah K Gustus; Christina Scirica; Bradley J Petek; Caroyln Vanatta; Timothy W Churchill; James Sawalla Guseh; Aaron Baggish; Meagan M Wasfy Journal: Br J Sports Med Date: 2022-05-18 Impact factor: 18.473
Authors: Peter Ladlow; Oliver O'Sullivan; Alexander N Bennett; Robert Barker-Davies; Andrew Houston; Rebecca Chamley; Samantha May; Daniel Mills; Dominic Dewson; Kasha Rogers-Smith; Christopher Ward; John Taylor; Joseph Mulae; Jon Naylor; Edward D Nicol; David A Holdsworth Journal: J Appl Physiol (1985) Date: 2022-05-19
Authors: Christopher C Huntley; Ketan Patel; Shahnoor-E-Salam Bil Bushra; Farah Mobeen; Michael N Armitage; Anita Pye; Chloe B Knight; Alyaa Mostafa; Marie Kershaw; Aishah Z Mughal; Emily McKemey; Alice M Turner; P Sherwood Burge; Gareth I Walters Journal: ERJ Open Res Date: 2022-05-30